rs6926723

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020442.6(VARS2):​c.190G>A​(p.Gly64Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0391 in 1,613,386 control chromosomes in the GnomAD database, including 2,013 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.065 ( 506 hom., cov: 32)
Exomes 𝑓: 0.036 ( 1507 hom. )

Consequence

VARS2
NM_020442.6 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.714

Publications

23 publications found
Variant links:
Genes affected
VARS2 (HGNC:21642): (valyl-tRNA synthetase 2, mitochondrial) This gene encodes a mitochondrial aminoacyl-tRNA synthetase, which catalyzes the attachment of valine to tRNA(Val) for mitochondrial translation. Mutations in this gene cause combined oxidative phosphorylation deficiency-20, and are also associated with early-onset mitochondrial encephalopathies. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2014]
VARS2 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • combined oxidative phosphorylation defect type 20
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015696287).
BP6
Variant 6-30915026-G-A is Benign according to our data. Variant chr6-30915026-G-A is described in ClinVar as Benign. ClinVar VariationId is 380189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VARS2NM_020442.6 linkc.190G>A p.Gly64Arg missense_variant Exon 2 of 30 ENST00000676266.1 NP_065175.4 Q5ST30-1B4E0K6B4DG77
VARS2NM_001167734.2 linkc.280G>A p.Gly94Arg missense_variant Exon 2 of 30 NP_001161206.1 Q5ST30-4A0A1U9X9B3
VARS2NM_001167733.3 linkc.-219-130G>A intron_variant Intron 1 of 28 NP_001161205.1 Q5ST30-3B4E0K6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VARS2ENST00000676266.1 linkc.190G>A p.Gly64Arg missense_variant Exon 2 of 30 NM_020442.6 ENSP00000502585.1 Q5ST30-1

Frequencies

GnomAD3 genomes
AF:
0.0646
AC:
9829
AN:
152124
Hom.:
504
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.126
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0891
Gnomad ASJ
AF:
0.0913
Gnomad EAS
AF:
0.0631
Gnomad SAS
AF:
0.0319
Gnomad FIN
AF:
0.0107
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0319
Gnomad OTH
AF:
0.0660
GnomAD2 exomes
AF:
0.0506
AC:
12562
AN:
248130
AF XY:
0.0467
show subpopulations
Gnomad AFR exome
AF:
0.124
Gnomad AMR exome
AF:
0.0992
Gnomad ASJ exome
AF:
0.0930
Gnomad EAS exome
AF:
0.0627
Gnomad FIN exome
AF:
0.00925
Gnomad NFE exome
AF:
0.0325
Gnomad OTH exome
AF:
0.0497
GnomAD4 exome
AF:
0.0365
AC:
53278
AN:
1461144
Hom.:
1507
Cov.:
36
AF XY:
0.0362
AC XY:
26295
AN XY:
726924
show subpopulations
African (AFR)
AF:
0.133
AC:
4443
AN:
33380
American (AMR)
AF:
0.0966
AC:
4313
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.0895
AC:
2340
AN:
26132
East Asian (EAS)
AF:
0.0616
AC:
2447
AN:
39700
South Asian (SAS)
AF:
0.0335
AC:
2885
AN:
86224
European-Finnish (FIN)
AF:
0.00981
AC:
520
AN:
53012
Middle Eastern (MID)
AF:
0.0596
AC:
344
AN:
5768
European-Non Finnish (NFE)
AF:
0.0297
AC:
33027
AN:
1111918
Other (OTH)
AF:
0.0490
AC:
2959
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2874
5748
8622
11496
14370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1360
2720
4080
5440
6800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0646
AC:
9842
AN:
152242
Hom.:
506
Cov.:
32
AF XY:
0.0638
AC XY:
4751
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.126
AC:
5245
AN:
41542
American (AMR)
AF:
0.0891
AC:
1363
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0913
AC:
317
AN:
3472
East Asian (EAS)
AF:
0.0632
AC:
327
AN:
5172
South Asian (SAS)
AF:
0.0317
AC:
153
AN:
4828
European-Finnish (FIN)
AF:
0.0107
AC:
114
AN:
10608
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0319
AC:
2168
AN:
68012
Other (OTH)
AF:
0.0649
AC:
137
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
457
913
1370
1826
2283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0444
Hom.:
804
Bravo
AF:
0.0748
TwinsUK
AF:
0.0294
AC:
109
ALSPAC
AF:
0.0319
AC:
123
ESP6500AA
AF:
0.117
AC:
354
ESP6500EA
AF:
0.0353
AC:
191
ExAC
AF:
0.0484
AC:
5866
Asia WGS
AF:
0.0560
AC:
194
AN:
3478
EpiCase
AF:
0.0366
EpiControl
AF:
0.0371

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 29, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 17, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.62
DANN
Benign
0.80
DEOGEN2
Benign
0.0034
T;T;.;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.067
N
LIST_S2
Benign
0.31
T;T;T;T
MetaRNN
Benign
0.0016
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M;.;.;.
PhyloP100
-0.71
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.1
N;N;N;N
REVEL
Benign
0.010
Sift
Benign
0.45
T;T;T;T
Sift4G
Benign
0.45
T;T;T;T
Polyphen
0.0
B;.;.;.
Vest4
0.026
MutPred
0.12
Gain of MoRF binding (P = 0.0157);Gain of MoRF binding (P = 0.0157);.;Gain of MoRF binding (P = 0.0157);
MPC
0.54
ClinPred
0.0061
T
GERP RS
-2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.047
gMVP
0.18
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6926723; hg19: chr6-30882803; COSMIC: COSV52558737; COSMIC: COSV52558737; API